MICR3002 Monday practical Bench D2 references

1. Rossi.S.L., Ross.M.T., Evans.J.D. West Nile Virus. 2011.Clinics in Laboratory Medicin.S0272-2712(09)00123-1 

2. Chappell.K.J., Stoermer. M.J., Fairlie.D.P. Fairlie.,Young. P.R. West Nile Virus NS2B/NS3 Protease As An Antiviral Target. 2008.Current medical chemistry. 15, 2771-2784

3. DeBiasi.R.L. West Nile Virus Neuroinvasive Disease.2011. DOI: 10.1007/s11908-011-0193-9

4. Hall.R.A., Nisbet.D.J., Pham.K.B., Pyke.A.T., Smith.G.A.,Khromykh.A.A.DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus.2003. doi: 10.1073/pnas.1834270100

5. Kramer.L.D.,Li.J.,Shi.P-Y.West Nile virus.2007.The Lancet Neurology.Elsevier

6. Murray. P.R., and Agrawal. A.G. West Nile Virus: Pathogenesis and Theraputic Options. 2004. Annal. Intern. Med. 140(7); 545-553

7. Wang. T., Town. T., Alexopoulou. L., Anderson. J. F., Fikrig. E., Flavell. R.A. Toll-like receptor 3 mediates West Nile Virus entry into the brain causing lethal encephalitis. 2004. Nature Medicine. 10(12); 1366-1373

8. Samuel. M.A and Diamond. M.S. Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion. 2006. J. Virol. 80(19); 9349-9360

9. Samuel. M.A., Morney. J.V., and Diamond. M.S. Capsase 3 dependent cell death of neurons contributes to the pathogenesis of West Nile Virus encephalitis. 2007. J. Virol. 81; 2614-26233

10. Lazear. H.M., Pinto. A.K., Vogt. M.R., Gale Jr. M., and Diamond. M.S. Beta Interferon

11. Controls West Nile Virus Infection and Pathogenesis in Mice. J. Virol. 2011, 85(14):7186

12. Dai. J., Wang. P., Bai. F., Town. T., Fikrig. E. ICAM-1 Participates in the Entry of West Nile Virus into the central nervous system. J. Virol. 2008, 82(8):4164

13. Biasi. R.L. West Nile Virus Neuroinvasive Disease. 2011 DO1: 10.1007/s11908-011-0193-9

14. Komar. N. West Nile Virus: Epidemiology and Ecology in North America. 2003. Advances in Virus Research: 61: 185-234

15. U.S. Centers for Disease Control & Prevent; Epidemiology and transmission dynamics of West Nile virus reviewed", 2005,Lab Business Week, , no. 15526461, pp. 232-232.

16. Hayes. E.B., Komar. N., Nasci. R.S., Montgomery. S.P., O’Leary. D.R., Campbell. G.L. Epidemiology and Transmission dynamics of West Nile Virus Disease. 2005. Emerg. Infect. Dis. 11(8): 1167-1173

17. Asnis D.S., Conetta R., Waldman G., and Teixeira A.A. 2006. The west nile virus encephalitis outbreak in the United State (1999-2000). Annals of the New York Academy of Sciences. 951:161-17

18. Peterson L.R., Roehrig J.T. 2001. West nile virus: a reemerging global pathogen. Emerging infectious diseases. 7(1):611-614

19. Nasci R.S. et al. 2001. West nile virus isolates from mosquitoes in New York and New Jersey, 1999. Emerging infectious diseases. 7(1):626-630

20. Nash D. et al. 2001. The outbreak of west nile virus infection in the New York city area in 1999. The New England Journal of Medicine. 344(24): 1807-1814

21. Millicent Eidson et al. (2001). Emerging Infectious Diseases, vol. 7, no. 4, July-August 2001

22. Denis Nash et al. (2001). The New England Journal of New Medicine - 344:1807-1814

23. B Lynn Johnston and John M Conly (2000). The Canadian Journal of Infectious Diseases - Jul-Aug; 11(4): 175–178.

24. Goudarz Molaei et al. (2006). Emerging Infectious Diseases – vol. 12, no. 3, March 2006